Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents
文献类型:期刊论文
作者 | Peng, Wei ; Tu, Zheng-Chao ; Long, Zi-Jie ; Liu, Quentin ; Lu, Gui |
刊名 | EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
![]() |
出版日期 | 2016 |
卷号 | 108页码:644-654 |
ISSN号 | 0223-5234 |
学科主题 | Pharmacology & Pharmacy |
语种 | 英语 |
公开日期 | 2016-12-16 |
源URL | [http://ir.gibh.ac.cn/handle/344009/900] ![]() |
专题 | 广州生物医药与健康研究院_华南干细胞与再生医学研究所_华南干细胞与再生医学研究所_期刊论文 |
推荐引用方式 GB/T 7714 | Peng, Wei,Tu, Zheng-Chao,Long, Zi-Jie,et al. Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents[J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,2016,108:644-654. |
APA | Peng, Wei,Tu, Zheng-Chao,Long, Zi-Jie,Liu, Quentin,&Lu, Gui.(2016).Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents.EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY,108,644-654. |
MLA | Peng, Wei,et al."Discovery of 2-(2-aminopyrimidin-5-yl)-4-morpholino-N-(pyridin-3-yl)quinazolin-7-amines as novel PI3K/mTOR inhibitors and anticancer agents".EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY 108(2016):644-654. |
入库方式: OAI收割
来源:广州生物医药与健康研究院
浏览0
下载0
收藏0
其他版本
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。